Hepatocellular carcinoma recurrence after directly acting antivirals for chronic hepatitis C: A 2-year follow-up study

4Citations
Citations of this article
5Readers
Mendeley users who have this article in their library.

Abstract

Aim of the study: Data regarding hepatocellular carcinoma (HCC) recurrence after directly acting antivirals for hepatitis C are contradictory. Our aim was to study the HCC recurrence in patients who received directly acting antivirals after tumor ablation. Material and methods: This retrospective study included all Child-Pugh A and B patients with hepatitis C related < 5 cm single or up to 3 HCC without any vascular or extrahepatic involvement whose lesions were managed using microwave or radiofrequency ablation at the Internal Medicine Department of Alexandria Faculty of Medicine, in the period from 1 January 2016 to 31 December 2016, and then received directly acting antivirals. Results: Data from 52 patients were analyzed. Throughout the 2 years from ablation, 42.3% of patients experienced tumor recurrence (22 out of 52 patients). In addition, two subjects died and 4 subjects were lost to follow-up before any tumor recurrence. Conclusions: Although our study included both modified Child-Pugh A and B patients and included lesions up to 5 cm treated using thermal ablation, the 2-year HCC recurrence rate was similar to that previously reported after surgical resection or radiofrequency ablation of lesions up to 3 cm in Child-Pugh A patients before development of directly acting antivirals.

Cite

CITATION STYLE

APA

Kamal, A., Elmoety, A. A. A., Rostom, Y. A., Shater, M. S., & Lashen, S. A. (2021). Hepatocellular carcinoma recurrence after directly acting antivirals for chronic hepatitis C: A 2-year follow-up study. Clinical and Experimental Hepatology, 7(1), 66–73. https://doi.org/10.5114/ceh.2021.104397

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free